Crossing Death Valley: Bringing Neurotechnology to Psychiatric Clinics in Alberta, Canada.

ABSTRACT: Depression is a major public health problem, with a lifetime and 12-month prevalence estimated at 18 and 6% of adults. Depression is costly in terms of treatment and lost productivity and is the main burden of mental illness across the globe. Existing pharmacological and psychological treatments for depression result in clinically meaningful improvements in <60% of patients. An emerging treatment approach is non-invasive brain stimulation of depression-related brain targets through transcranial magnetic stimulation (TMS). In this perspective, we detail our efforts on bringing TMS to clinical populations in Alberta by utilizing a novel organizational structure that bridges the gap between academia and the health care system. The Addictions and Mental Health Strategic Clinical Network worked

SUBMITTER: MacMaster FP 

PROVIDER: S-EPMC7067696 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature